DEINOVE announces a favorable opinion from the DSMB for the continuation of the Phase II clinical trial of DNV3837 in Clostridioides difficile infections

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

Matthew Durham
Omnidynamic Marketing